Sponsor Pipeline

Grupo Español de Investigación en Cáncer de Ovario Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07013851 Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients… MMRd/MSI-H Stage II-III Endometrial Cancer Not Yet Recruiting
NCT03833479 TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical… Cervical Cancer Active, Not Recruiting
Disease Areas
Get alerts when Grupo Español de Investigación en Cáncer de Ovario's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free